You are here

  • Home
  • Archive
  • Volume 33, Issue 11
  • Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

Article metrics

Article menu

Download PDFPDF

Original research
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 2023511500187
Dec 202332529075
Jan 202418715236
Feb 2024828234
Mar 2024888667
Apr 2024969344
May 2024323226
Jun 2024757044
Jul 2024767626
Aug 2024484322
Sep 2024686429
Oct 2024999
Total15971497599